Exact Sciences Has an Established Colon Cancer Screening Franchise and a Progressing Pipeline
Exact Sciences has a multipronged approach to cancer testing. Current products are Cologuard, its flagship stool-based screening test for colorectal cancer, or CRC, and Oncotype DX, its tissue-based ...
Platform trials streamline ALS therapy evaluation by rapidly ruling out ineffective drugs
Massachusetts General Hospital coordinated the first four platform trials within the HEALEY ALS platform to evaluate ...
BMJ1d
Climate footprint of industry-sponsored in-human clinical trials: life cycle assessments of clinical trials spanning multiple phases and disease areas
The involved trials were selected to show diversity and may not be representative of all trials of their type. Due to resource limitations, the sample size remains limited. Despite the limitations, ...
How Can Clinical Trials Improve Diversity? CTM’s Cara Brant Explains
Historically, clinical trials have under-represented women and minorities. Clinical Trial Media's Cara Brant offers ...
News Medical2d
Nerinetide shows promise in stroke treatment meta-analysis
The Calgary Stroke Program, a joint University of Calgary and Alberta Health Services initiative at Foothills Medical Centre, has been involved with three papers published this week in The Lancet and ...
It’s not just AI. China’s medicines are surprising the world, too
In recent months China’s progress in artificial intelligence has stunned the world. A quieter, yet equally significant shift ...
Science Daily6d
New blood test identifies hard-to-detect pancreatic cancer with 85% accuracy
A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the deadliest cancers.